“…The test has been validated in a wide variety of veteran samples (veterans with comorbid posttraumatic stress disorder (PTSD) and concussion, Nelson et al, 2011; sexually traumatized female veterans, Arbisi, Erbes, Polusny, & Nelson, 2010; soldiers with mild traumatic brain injury, Arbisi, Polusny, Erbes, Thuras, & Reddy, 2011); in these studies, some small, but mostly medium to large effect sizes were reported. Its validity scales have been previously found to detect cognitive/somatic (Jones & Ingram, 2011; Jones, Ingram, & Ben-Porath, 2012; Young, Kearns, & Roper, 2011) and/or psychiatric symptom overreporting (Tolin, Steenkamp, Marx, & Litz, 2010) in veterans, generally demonstrating moderate to large effect sizes. However, despite the potential theoretical and clinical relevance of the MMPI-2-RF domains for assessing varying levels of suicide risk, no studies to date have examined the utility of the MMPI-2-RF for this purpose in veteran populations.…”